Take a look at something like THRM for comparison — another company working on saliva based COVID-19 test. It has triple the mkt cap, more than triple the float, tons of cheap paper as low as .05, almost zero in revenues. Current WAVE valuation makes no sense given $1M cash position, 300K+ quarterly revs and no paper overhang. The only issue to date has been market awareness but volume suggests
...more